197 related articles for article (PubMed ID: 12234922)
1. Modulation of T-lymphocyte development, growth and cell size by the Myc antagonist and transcriptional repressor Mad1.
Iritani BM; Delrow J; Grandori C; Gomez I; Klacking M; Carlos LS; Eisenman RN
EMBO J; 2002 Sep; 21(18):4820-30. PubMed ID: 12234922
[TBL] [Abstract][Full Text] [Related]
2. Co-induction of Mad1 and c-Myc in activated normal B lymphocytes.
Ertesvåg A; Blomhoff HK; Beiske K; Naderi S
Scand J Immunol; 2000 Jun; 51(6):565-70. PubMed ID: 10849366
[TBL] [Abstract][Full Text] [Related]
3. Mad1 expression in the absence of differentiation: effect of cAMP on the B-lymphoid cell line Reh.
Naderi S; Blomhoff HK
J Cell Physiol; 1999 Jan; 178(1):76-84. PubMed ID: 9886493
[TBL] [Abstract][Full Text] [Related]
4. Myc and Mad bHLHZ domains possess identical DNA-binding specificities but only partially overlapping functions in vivo.
James L; Eisenman RN
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10429-34. PubMed ID: 12149476
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cell proliferation by the Mad1 transcriptional repressor.
Roussel MF; Ashmun RA; Sherr CJ; Eisenman RN; Ayer DE
Mol Cell Biol; 1996 Jun; 16(6):2796-801. PubMed ID: 8649388
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Myc/Max/Mad network members in adipogenesis: inhibition of the proliferative burst and differentiation by ectopically expressed Mad1.
Pulverer B; Sommer A; McArthur GA; Eisenman RN; Lüscher B
J Cell Physiol; 2000 Jun; 183(3):399-410. PubMed ID: 10797315
[TBL] [Abstract][Full Text] [Related]
7. MAD1 and c-MYC regulate UBF and rDNA transcription during granulocyte differentiation.
Poortinga G; Hannan KM; Snelling H; Walkley CR; Jenkins A; Sharkey K; Wall M; Brandenburger Y; Palatsides M; Pearson RB; McArthur GA; Hannan RD
EMBO J; 2004 Aug; 23(16):3325-35. PubMed ID: 15282543
[TBL] [Abstract][Full Text] [Related]
8. Repression of in vivo growth of Myc/Ras transformed tumor cells by Mad1.
Cerni C; Skrzypek B; Popov N; Sasgary S; Schmidt G; Larsson LG; Lüscher B; Henriksson M
Oncogene; 2002 Jan; 21(3):447-59. PubMed ID: 11821957
[TBL] [Abstract][Full Text] [Related]
9. Expression of Mad1 in T cells leads to reduced thymic cellularity and impaired mitogen-induced proliferation.
Rudolph B; Hueber AO; Evan GI
Oncogene; 2001 Mar; 20(10):1164-75. PubMed ID: 11313860
[TBL] [Abstract][Full Text] [Related]
10. Mad1 is a transcriptional repressor of Bcl-6.
Lee SC; Bottaro A; Chen L; Insel RA
Mol Immunol; 2006 May; 43(12):1965-71. PubMed ID: 16423395
[TBL] [Abstract][Full Text] [Related]
11. Myc/Max/Mad regulate the frequency but not the duration of productive cell cycles.
Hölzel M; Kohlhuber F; Schlosser I; Hölzel D; Lüscher B; Eick D
EMBO Rep; 2001 Dec; 2(12):1125-32. PubMed ID: 11743027
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the DNA-binding activities of Myc/Max/Mad network complexes during induced differentiation of U-937 monoblasts and F9 teratocarcinoma cells.
Larsson LG; Bahram F; Burkhardt H; Lüscher B
Oncogene; 1997 Aug; 15(6):737-48. PubMed ID: 9264414
[TBL] [Abstract][Full Text] [Related]
13. Hyperresponse to T-cell receptor signaling and apoptosis of Id1 transgenic thymocytes.
Qi Z; Sun XH
Mol Cell Biol; 2004 Sep; 24(17):7313-23. PubMed ID: 15314144
[TBL] [Abstract][Full Text] [Related]
14. Zinc modulates c-Myc/Mad1 balance in human leukemia cells.
Sirinian MI; Pisegna S; Paroli M; Militi S; Testa U; Peschle C
Leukemia; 2003 Jan; 17(1):272-4. PubMed ID: 12529695
[No Abstract] [Full Text] [Related]
15. Inhibition of proliferation and apoptosis by the transcriptional repressor Mad1. Repression of Fas-induced caspase-8 activation.
Gehring S; Rottmann S; Menkel AR; Mertsching J; Krippner-Heidenreich A; Lüscher B
J Biol Chem; 2000 Apr; 275(14):10413-20. PubMed ID: 10744730
[TBL] [Abstract][Full Text] [Related]
16. Mmip-2, a novel RING finger protein that interacts with mad members of the Myc oncoprotein network.
Yin XY; Gupta K; Han WP; Levitan ES; Prochownik EV
Oncogene; 1999 Nov; 18(48):6621-34. PubMed ID: 10597267
[TBL] [Abstract][Full Text] [Related]
17. Function of the c-Myc antagonist Mad1 during a molecular switch from proliferation to differentiation.
Cultraro CM; Bino T; Segal S
Mol Cell Biol; 1997 May; 17(5):2353-9. PubMed ID: 9111304
[TBL] [Abstract][Full Text] [Related]
18. Expression and mutation analysis of genes that encode the Myc antagonists Mad1, Mxi1 and Rox in acute leukaemia.
Guo XL; Pan L; Zhang XJ; Suo XH; Niu ZY; Zhang JY; Wang F; Dong ZR; Da W; Ohno R
Leuk Lymphoma; 2007 Jun; 48(6):1200-7. PubMed ID: 17577784
[TBL] [Abstract][Full Text] [Related]
19. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
Gupta K; Anand G; Yin X; Grove L; Prochownik EV
Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
[TBL] [Abstract][Full Text] [Related]
20. Cell-cycle progression is not essential for c-Myc to block differentiation.
Ryan KM; Birnie GD
Oncogene; 1997 Jun; 14(23):2835-43. PubMed ID: 9190900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
